Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amgen discloses novel CaSR ligands for treating hyperparathyroidism and other conditions

Feb. 27, 2009

Roche imparts novel antidiabetic 11beta-HSD1 inhibitors

Feb. 27, 2009

New GPR119 receptor agonists for treating diabetes reported in recent Bristol-Myers Squibb patent

Feb. 27, 2009

Novel orally active quinoline derivative potently and selectively inhibits CETP

Feb. 27, 2009

Novartis patents novel PTPase inhibitors with antidiabetic properties

Feb. 26, 2009

Penwest commences phase Ib A-0001 trial for mitochondrial diseases

Feb. 26, 2009

Alexion's Soliris receives marketing approval in Australia for PNH

Feb. 26, 2009

Merck & Co. conducting phase IIa study to evaluate the safety and efficacy of MK-8245

Feb. 26, 2009

Orexin receptor-2 agonism inhibits diet-induced obesity in mice

Feb. 25, 2009

CPEX initiates phase II Nasulin trial in type 2 diabetes

Feb. 25, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...